← Eichor
Study identifier: NCT06044922 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Heart Rate Variability in Early Prediction of a Noxic Brain Injury After Cardiac Arrest

Condition: Cardiac Arrest  ·  Sponsor: CMC Ambroise Paré

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Despite advances in post-resuscitation care of patients with cardiac arrest (CA), the majority of survivors who are treated after restoration of spontaneous circulation (ROSC) will have sequelae of hypoxic-ischemic brain injury ranging from mild cognitive impairment to a vegetative state. Early prognostication in comatose patients after ROSC remains challenging. Recent recommendations suggest carrying out clinical and paraclinical tests during the first 72 h after ROSC, to predict a poor neurological outcome with a specificity greater than 95% (no pupillary and corneal reflexes, bilaterally absent N20 somatosensory evoked potential wave, status myoclonus, highly malignant electroencephalography including suppressed background ± periodic discharges or burst-suppression, neuron-specific enolase (NSE) \> 60 µg/L, a diffuse and extensive anoxic injury on brain CT/MRI), but with a low sensitivity due to frequent confounding factors. The heart rate variability (HRV) is a simple and non-invasive technique for assessing the autonomic nervous system function. In patients with a recent myocardial infarction, reduced HRV is associated with an increased risk for malignant arrhythmias or death. In neurology, reduced HRV is associated with a poor outcome in severe brain injury patients and allows to predict early neurological deterioration and recurrent ischemic stroke after acute ischemic stroke. A reduced HRV could be a sensitive, specific and early indicator of diffuse anoxic brain i…

This description comes directly from the study's public registry record.

Talk to the study team

Guillaume GERI, MD, PhD  ·  0146415079  ·  guillaume.geri@clinique-a-pare.fr

Cécile NAUDIN, PhD  ·  cecile.naudin@clinique-a-pare.fr

Always discuss trial participation with your own doctor first.

Locations (5)

Brest University HospitalBrest, Brittany Region, FranceRecruiting
Nantes University HospitalNantes, Pays de la Loire Region, FranceRecruiting
Marseille University HospitalMarseille, Provence-Alpes-Côte d'Azur Region, FranceRecruiting
Ambroise Paré - Hartmann Private Hospital GroupNeuilly-sur-Seine, Île-de-France Region, FranceRecruiting
Cochin HospitalParis, Île-de-France Region, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06044922